FDA Approves First Pill For Postpartum Depression Treatment, Replacing IV Injections
The U.S. Food and Drug Administration (FDA) has approved the first breakthrough pill to treat postpartum depression (PPD), the agency said in a press release Friday. The Sage Therapeutics product Zurzvae (Zranolone) is designed to address “depressive episodes that usually occur after childbirth but can also begin later in pregnancy.” according to FDA. The tablet, […]
